TESTING CHOLESTEROL REPLENISHMENT IN PRODROMAL HUNTINGTON’S DISEASE: EFFECTS ON CIRCUIT-SPECIFIC SYNAPTIC RESPONSES AND PLASTICITY
Università Telematica San Raffaele
Presentation
Date TBA
Event Information
Poster Board
PS05-09AM-288
Poster
View posterAbstract
We characterized early cortico-striatal synaptopathy in a mouse model of prodromal HD, which presented with cognitive decline but no overt motor manifestations. In this setting, we tested whether central cholesterol delivery could prevent the onset of cortico-striatal synaptic dysfunction.
After systemic chronic treatment with brain-permeable nanoparticles loaded with cholesterol, 20-week-old zQ175DN knock-in mice were tested through ex vivo patch-clamp recordings and optogenetic stimulation to assess circuit-specific excitatory neurotransmission and synaptic plasticity. Immunofluorescence, electron microscopy, and molecular analysis of striatal synaptosomes were used for structural characterization.
In prodromal HD mice, we found reduced density of cortico-striatal projections and impaired excitatory tone. Long-term synaptic plasticity is lost in both striatal medium spiny neurons and cholinergic interneurons. We further investigated this phenomenon by pharmacologically isolating AMPAR- and NMDAR-mediated postsynaptic currents. Biochemical characterization of striatal synaptosomes highlighted a possible molecular link between cholesterol dysfunction and early synaptopathy. The effects of preemptive cholesterol administration on excitatory neurotransmission and long-term plasticity were tested, and electrophysiological outcomes were further validated by testing putative cholesterol-binding proteins in striatal synaptosomes.
Our work demonstrated that cortico-striatal disconnection can be assessed as early as in premotor HD, and that it is sustained by both presynaptic and postsynaptic phenomena. Cholesterol dyshomeostasis plays a role in cortico-striatal synaptopathy and may represent a potential target for halting network dysfunction in HD.
Recommended posters
CHOROID PLEXUS DYSFUNCTION AND ITS IMPACT ON CORTICAL PLASTICITY TIMING IN HUNTINGTON DISEASE
Fanny Namysl, Gisela D'Angelo, Ariel Di Nardo, Alexandra Durr, Sandrine Humbert
STEALTHY VULNERABILITIES: ATYPICAL POSTNATAL DEVELOPMENT OF THE STRIATAL CONNECTOME IN A MOUSE MODEL OF HUNTINGTON’S DISEASE
Sabrina Villar Pazos, Cristina Vila, Anna Krskova, Olga Varea, Samuele Maturi, Josep M. Canals, Sofia Grade
CORTISTATIN AS A NOVEL THERAPEUTIC TARGET FOR HUNTINGTON'S DISEASE MODULATING NEUROINFLAMMATION AND MITOCHONDRIAL INTEGRITY
Pilar González García, Ignacio Serrano Martínez, Eliana Barriocanal Casado, Alejandro Cuenca Martagón, Pablo Vargas Rodríguez, Irene Forte Lago, Patricia Gómez Suaga, Silvia Ginés, Luis C López, Elena González Rey
A STRATEGY FOR RESTORING CHOLESTEROL-DEPENDENT SHH SIGNALLING IN A LIPID STORAGE NEURODEVELOPMENTAL DISORDER
Francesco Trenta, Roberta Stefanelli, Chiara Projetti, Alessandro Palma, Valentina Chiodi, Sonia Canterini, Maria Teresa Fiorenza
EXPLORING THE DEVELOPING CEREBELLUM IN HUNTINGTON DISEASE (HD)
Melika Ghaznavirad, Alexandra Durr, Sandrine Humbert
IN VITRO ANALYSIS OF NEURONAL INFLAMMATORY RESPONSE AND NLRP3 INFLAMMASOME INHIBITION IN A HUNTINGTON’S DISEASE MODEL
Giulia Rossi, Laura Coculo, Marco Fiocchetti